BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884 AND Prognosis
19 results:

  • 1. Profiling Kinase Activities for Precision Oncology in Diffuse gastric cancer.
    Singh S; Parthasarathi KTS; Bhat MY; Gopal C; Sharma J; Pandey A
    OMICS; 2024 Feb; 28(2):76-89. PubMed ID: 38271566
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. LINC01226 promotes gastric cancer progression through enhancing cytoplasm-to-nucleus translocation of STIP1 and stabilizing β-catenin protein.
    Hua H; Su T; Han L; Zhang L; Huang Y; Zhang N; Yang M
    Cancer Lett; 2023 Nov; 577():216436. PubMed ID: 37806517
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Exploring the Potential Mechanism of Action of Ursolic Acid against gastric cancer and COVID-19 using Network Pharmacology and Bioinformatics Analysis.
    Liu Z; Huang H; Yu Y; Jia Y; Li L; Shi X; Wang F
    Curr Pharm Des; 2023; 29(16):1274-1292. PubMed ID: 37218202
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Current status of and future prospects for the treatment of unresectable or metastatic gastrointestinal stromal tumours.
    Naito Y; Nishida T; Doi T
    Gastric Cancer; 2023 May; 26(3):339-351. PubMed ID: 36913072
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. gastric cancer derived mesenchymal stem cells promoted DNA repair and cisplatin resistance through up-regulating PD-L1/Rad51 in gastric cancer.
    Wang Q; Huang C; Wang D; Tao Z; Zhang H; Zhao Y; Wang M; Zhou C; Xu J; Shen B; Zhu W
    Cell Signal; 2023 Jun; 106():110639. PubMed ID: 36842523
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Exploring the mechanism of andrographolide in the treatment of gastric cancer through network pharmacology and molecular docking.
    Yadav RP; Sadhukhan S; Saha ML; Ghosh S; Das M
    Sci Rep; 2022 Nov; 12(1):18413. PubMed ID: 36319798
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. OCT4-mediated transcription confers oncogenic advantage for a subset of gastric tumors with poor clinical outcome.
    Pandian J; Panneerpandian P; Sekar BT; Selvarasu K; Ganesan K
    Funct Integr Genomics; 2022 Dec; 22(6):1345-1360. PubMed ID: 35987846
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comprehensive Analysis of Epigenetic Associated Genes with Differential Gene Expression and prognosis in gastric cancer.
    An S; Li X; Li B; Li Y
    Comb Chem High Throughput Screen; 2023; 26(3):527-538. PubMed ID: 35570548
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p/HUR/VEGF axis and suppressing hsp90 degradation.
    Xie M; Yu T; Jing X; Ma L; Fan Y; Yang F; Ma P; Jiang H; Wu X; Shu Y; Xu T
    Mol Cancer; 2020 Jun; 19(1):112. PubMed ID: 32600329
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical significance of heat shock protein 90α expression as a biomarker of prognosis in patients with gastric cancer.
    Lee HW; Kim KM
    Niger J Clin Pract; 2019 Dec; 22(12):1698-1705. PubMed ID: 31793477
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Stress-induced phosphoprotein 1 promotes pancreatic cancer progression through activation of the FAK/AKT/MMP signaling axis.
    Jing Y; Liang W; Liu J; Zhang L; Wei J; Zhu Y; Yang J; Ji K; Zhang Y; Huang Z
    Pathol Res Pract; 2019 Nov; 215(11):152564. PubMed ID: 31547977
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Is co-expression of USP22 and hsp90 more effective in predicting prognosis of gastric cancer?
    Zheng H; Yu J; Li W; Yang D; Gao C; Zhang Q; Xu L
    Pathol Res Pract; 2019 Apr; 215(4):653-659. PubMed ID: 30598339
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Bovine Hemoglobin Derived Peptide Asn-Phe-Gly-Lys Inhibits Pancreatic cancer Cells Metastasis by Targeting Secreted hsp90α.
    Wang Y; Zhang T; Zhang H; Yang H; Li Y; Jiang Y
    J Food Sci; 2017 Dec; 82(12):3005-3012. PubMed ID: 29083493
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Therapeutic potency of heat-shock protein-90 pharmacological inhibitors in the treatment of gastrointestinal cancer, current status and perspectives.
    Boroumand N; Saghi H; Avan A; Bahreyni A; Ryzhikov M; Khazaei M; Hassanian SM
    J Pharm Pharmacol; 2018 Feb; 70(2):151-158. PubMed ID: 28980313
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinical, Prognostic and Therapeutic Significance of Heat Shock Proteins in cancer.
    Saini J; Sharma PK
    Curr Drug Targets; 2018; 19(13):1478-1490. PubMed ID: 28831912
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Heat Shock Protein Association with Clinico-Pathological Characteristics of gastric cancer in Jordan : HSP70 is Predictive of Poor prognosis.
    Bodoor K; Jalboush SA; Matalka I; Abu-Sheikha A; Waq RA; Ebwaini H; Abu-Awad A; Fayyad L; Al-Arjat J; Haddad Y
    Asian Pac J Cancer Prev; 2016; 17(8):3929-37. PubMed ID: 27644641
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Association between hsp90 and Her2 in gastric and gastroesophageal carcinomas.
    Berezowska S; Novotny A; Bauer K; Feuchtinger A; Slotta-Huspenina J; Becker K; Langer R; Walch A
    PLoS One; 2013; 8(7):e69098. PubMed ID: 23874879
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. High expression of heat shock protein 90 is associated with tumor aggressiveness and poor prognosis in patients with advanced gastric cancer.
    Wang J; Cui S; Zhang X; Wu Y; Tang H
    PLoS One; 2013; 8(4):e62876. PubMed ID: 23638161
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. gastric cancer and metastasis to the brain.
    York JE; Stringer J; Ajani JA; Wildrick DM; Gokaslan ZL
    Ann Surg Oncol; 1999 Dec; 6(8):771-6. PubMed ID: 10622506
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.